The global Non- Alcoholic Steatohepatitis Treatment market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Non- Alcoholic Steatohepatitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Non- Alcoholic Steatohepatitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non- Alcoholic Steatohepatitis Treatment. This report contains market size and forecasts of Non- Alcoholic Steatohepatitis Treatment in global, including the following market information:
Global Non- Alcoholic Steatohepatitis Treatment market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Non- Alcoholic Steatohepatitis Treatment companies in 2024 (%)
Total Market by Segment:
Global Non- Alcoholic Steatohepatitis Treatment market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Non- Alcoholic Steatohepatitis Treatment market segment percentages, by Type, 2024 (%)
Cenicriviroc
Aramchol
Resmetirom
Semaglutide
Lanifibranor
Obeticholic Acid (OCA)
Global Non- Alcoholic Steatohepatitis Treatment market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Non- Alcoholic Steatohepatitis Treatment market segment percentages, by Application, 2024 (%)
Retail & Specialty Pharmacies
Hospital Pharmacies
Others
Global Non- Alcoholic Steatohepatitis Treatment market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Non- Alcoholic Steatohepatitis Treatment market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non- Alcoholic Steatohepatitis Treatment revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Non- Alcoholic Steatohepatitis Treatment revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Bristol Myers Squibb
Novo Nordisk
NGM Biopharmaceuticals
Galectin Therapeutics
Inventiva Pharma
Intercept Pharmaceuticals
AbbVie
Madrigal Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non- Alcoholic Steatohepatitis Treatment, market overview.
Chapter 2: Global Non- Alcoholic Steatohepatitis Treatment market size in revenue.
Chapter 3: Detailed analysis of Non- Alcoholic Steatohepatitis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non- Alcoholic Steatohepatitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non- Alcoholic Steatohepatitis Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Non- Alcoholic Steatohepatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non- Alcoholic Steatohepatitis Treatment Overall Market Size
2.1 Global Non- Alcoholic Steatohepatitis Treatment Market Size: 2024 VS 2032
2.2 Global Non- Alcoholic Steatohepatitis Treatment Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non- Alcoholic Steatohepatitis Treatment Players in Global Market
3.2 Top Global Non- Alcoholic Steatohepatitis Treatment Companies Ranked by Revenue
3.3 Global Non- Alcoholic Steatohepatitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Non- Alcoholic Steatohepatitis Treatment Companies in Global Market, by Revenue in 2024
3.5 Global Companies Non- Alcoholic Steatohepatitis Treatment Product Type
3.6 Tier 1, Tier 2, and Tier 3 Non- Alcoholic Steatohepatitis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Non- Alcoholic Steatohepatitis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Non- Alcoholic Steatohepatitis Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Non- Alcoholic Steatohepatitis Treatment Market Size Markets, 2024 & 2032
4.1.2 Cenicriviroc
4.1.3 Aramchol
4.1.4 Resmetirom
4.1.5 Semaglutide
4.1.6 Lanifibranor
4.1.7 Obeticholic Acid (OCA)
4.2 Segmentation by Type - Global Non- Alcoholic Steatohepatitis Treatment Revenue & Forecasts
4.2.1 Segmentation by Type - Global Non- Alcoholic Steatohepatitis Treatment Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Non- Alcoholic Steatohepatitis Treatment Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Non- Alcoholic Steatohepatitis Treatment Market Size, 2024 & 2032
5.1.2 Retail & Specialty Pharmacies
5.1.3 Hospital Pharmacies
5.1.4 Others
5.2 Segmentation by Application - Global Non- Alcoholic Steatohepatitis Treatment Revenue & Forecasts
5.2.1 Segmentation by Application - Global Non- Alcoholic Steatohepatitis Treatment Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Non- Alcoholic Steatohepatitis Treatment Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Non- Alcoholic Steatohepatitis Treatment Market Size, 2024 & 2032
6.2 By Region - Global Non- Alcoholic Steatohepatitis Treatment Revenue & Forecasts
6.2.1 By Region - Global Non- Alcoholic Steatohepatitis Treatment Revenue, 2020-2025
6.2.2 By Region - Global Non- Alcoholic Steatohepatitis Treatment Revenue, 2026-2032
6.2.3 By Region - Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Non- Alcoholic Steatohepatitis Treatment Revenue, 2020-2032
6.3.2 United States Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.3.3 Canada Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.3.4 Mexico Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Non- Alcoholic Steatohepatitis Treatment Revenue, 2020-2032
6.4.2 Germany Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.4.3 France Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.4.4 U.K. Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.4.5 Italy Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.4.6 Russia Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.4.7 Nordic Countries Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.4.8 Benelux Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Non- Alcoholic Steatohepatitis Treatment Revenue, 2020-2032
6.5.2 China Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.5.3 Japan Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.5.4 South Korea Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.5.5 Southeast Asia Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.5.6 India Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Non- Alcoholic Steatohepatitis Treatment Revenue, 2020-2032
6.6.2 Brazil Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.6.3 Argentina Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Revenue, 2020-2032
6.7.2 Turkey Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.7.3 Israel Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.7.4 Saudi Arabia Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
6.7.5 UAE Non- Alcoholic Steatohepatitis Treatment Market Size, 2020-2032
7 Companies Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Corporate Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Major Product Offerings
7.1.4 Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Revenue in Global Market (2020-2025)
7.1.5 Gilead Sciences Key News & Latest Developments
7.2 Bristol Myers Squibb
7.2.1 Bristol Myers Squibb Corporate Summary
7.2.2 Bristol Myers Squibb Business Overview
7.2.3 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Major Product Offerings
7.2.4 Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Revenue in Global Market (2020-2025)
7.2.5 Bristol Myers Squibb Key News & Latest Developments
7.3 Novo Nordisk
7.3.1 Novo Nordisk Corporate Summary
7.3.2 Novo Nordisk Business Overview
7.3.3 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Major Product Offerings
7.3.4 Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Revenue in Global Market (2020-2025)
7.3.5 Novo Nordisk Key News & Latest Developments
7.4 NGM Biopharmaceuticals
7.4.1 NGM Biopharmaceuticals Corporate Summary
7.4.2 NGM Biopharmaceuticals Business Overview
7.4.3 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Major Product Offerings
7.4.4 NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Revenue in Global Market (2020-2025)
7.4.5 NGM Biopharmaceuticals Key News & Latest Developments
7.5 Galectin Therapeutics
7.5.1 Galectin Therapeutics Corporate Summary
7.5.2 Galectin Therapeutics Business Overview
7.5.3 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Major Product Offerings
7.5.4 Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Revenue in Global Market (2020-2025)
7.5.5 Galectin Therapeutics Key News & Latest Developments
7.6 Inventiva Pharma
7.6.1 Inventiva Pharma Corporate Summary
7.6.2 Inventiva Pharma Business Overview
7.6.3 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Major Product Offerings
7.6.4 Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Revenue in Global Market (2020-2025)
7.6.5 Inventiva Pharma Key News & Latest Developments
7.7 Intercept Pharmaceuticals
7.7.1 Intercept Pharmaceuticals Corporate Summary
7.7.2 Intercept Pharmaceuticals Business Overview
7.7.3 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Major Product Offerings
7.7.4 Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Revenue in Global Market (2020-2025)
7.7.5 Intercept Pharmaceuticals Key News & Latest Developments
7.8 AbbVie
7.8.1 AbbVie Corporate Summary
7.8.2 AbbVie Business Overview
7.8.3 AbbVie Non- Alcoholic Steatohepatitis Treatment Major Product Offerings
7.8.4 AbbVie Non- Alcoholic Steatohepatitis Treatment Revenue in Global Market (2020-2025)
7.8.5 AbbVie Key News & Latest Developments
7.9 Madrigal Pharmaceuticals
7.9.1 Madrigal Pharmaceuticals Corporate Summary
7.9.2 Madrigal Pharmaceuticals Business Overview
7.9.3 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Major Product Offerings
7.9.4 Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Revenue in Global Market (2020-2025)
7.9.5 Madrigal Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Non- Alcoholic Steatohepatitis Treatment Market Opportunities & Trends in Global Market
Table 2. Non- Alcoholic Steatohepatitis Treatment Market Drivers in Global Market
Table 3. Non- Alcoholic Steatohepatitis Treatment Market Restraints in Global Market
Table 4. Key Players of Non- Alcoholic Steatohepatitis Treatment in Global Market
Table 5. Top Non- Alcoholic Steatohepatitis Treatment Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Non- Alcoholic Steatohepatitis Treatment Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Non- Alcoholic Steatohepatitis Treatment Revenue Share by Companies, 2020-2025
Table 8. Global Companies Non- Alcoholic Steatohepatitis Treatment Product Type
Table 9. List of Global Tier 1 Non- Alcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non- Alcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2026-2032
Table 30. Gilead Sciences Corporate Summary
Table 31. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Product Offerings
Table 32. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2020-2025)
Table 33. Gilead Sciences Key News & Latest Developments
Table 34. Bristol Myers Squibb Corporate Summary
Table 35. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Product Offerings
Table 36. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2020-2025)
Table 37. Bristol Myers Squibb Key News & Latest Developments
Table 38. Novo Nordisk Corporate Summary
Table 39. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Product Offerings
Table 40. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2020-2025)
Table 41. Novo Nordisk Key News & Latest Developments
Table 42. NGM Biopharmaceuticals Corporate Summary
Table 43. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Offerings
Table 44. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2020-2025)
Table 45. NGM Biopharmaceuticals Key News & Latest Developments
Table 46. Galectin Therapeutics Corporate Summary
Table 47. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Product Offerings
Table 48. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2020-2025)
Table 49. Galectin Therapeutics Key News & Latest Developments
Table 50. Inventiva Pharma Corporate Summary
Table 51. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Product Offerings
Table 52. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2020-2025)
Table 53. Inventiva Pharma Key News & Latest Developments
Table 54. Intercept Pharmaceuticals Corporate Summary
Table 55. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Offerings
Table 56. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2020-2025)
Table 57. Intercept Pharmaceuticals Key News & Latest Developments
Table 58. AbbVie Corporate Summary
Table 59. AbbVie Non- Alcoholic Steatohepatitis Treatment Product Offerings
Table 60. AbbVie Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2020-2025)
Table 61. AbbVie Key News & Latest Developments
Table 62. Madrigal Pharmaceuticals Corporate Summary
Table 63. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Product Offerings
Table 64. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Revenue (US$, Mn) & (2020-2025)
Table 65. Madrigal Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Non- Alcoholic Steatohepatitis Treatment Product Picture
Figure 2. Non- Alcoholic Steatohepatitis Treatment Segment by Type in 2024
Figure 3. Non- Alcoholic Steatohepatitis Treatment Segment by Application in 2024
Figure 4. Global Non- Alcoholic Steatohepatitis Treatment Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Non- Alcoholic Steatohepatitis Treatment Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Non- Alcoholic Steatohepatitis Treatment Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Non- Alcoholic Steatohepatitis Treatment Revenue in 2024
Figure 9. Segmentation by Type � Global Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
Figure 13. By Region - Global Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
Figure 14. By Country - North America Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
Figure 15. United States Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
Figure 19. Germany Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 20. France Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
Figure 27. China Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 31. India Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
Figure 33. Brazil Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Non- Alcoholic Steatohepatitis Treatment Revenue Market Share, 2020-2032
Figure 36. Turkey Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Non- Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2020-2032
Figure 40. Gilead Sciences Non- Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Bristol Myers Squibb Non- Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Novo Nordisk Non- Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. NGM Biopharmaceuticals Non- Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Galectin Therapeutics Non- Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Inventiva Pharma Non- Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Intercept Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. AbbVie Non- Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Madrigal Pharmaceuticals Non- Alcoholic Steatohepatitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
